TransCode Therapeutics Inc (NASDAQ: RNAZ) is -76.85% lower on its value in year-to-date trading and has touched a low of $0.64 and a high of $66.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $0.78 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.78, the stock is -78.22% and -85.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.55 million and changing 0.28% at the moment leaves the stock -94.66% off its SMA200. RNAZ registered -96.39% loss for a year compared to 6-month gain of -90.66%. The firm has a 50-day simple moving average (SMA 50) of $5.3523 and a 200-day simple moving average (SMA200) of $14.619585.
The stock witnessed a -92.68% loss in the last 1 month and extending the period to 3 months gives it a -90.11%, and is -43.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.86% over the week and 24.35% over the month.
TransCode Therapeutics Inc (RNAZ) has around 10 employees, a market worth around $0.54M and $0.00M in sales. Distance from 52-week low is 20.93% and -98.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-903.45%).
with sales reaching $300k over the same period.The EPS is expected to grow by 95.41% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
TransCode Therapeutics Inc (RNAZ) Top Institutional Holders
11.0 institutions hold shares in TransCode Therapeutics Inc (RNAZ), with institutional investors hold 22.37% of the company’s shares. The shares outstanding are 0.70M, and float is at 0.66M with Short Float at 81.96%. Institutions hold 22.36% of the Float.
TransCode Therapeutics Inc (RNAZ) Insider Activity
#####